Drugs / Carbimazole
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00430547 | Aug 2003 → Jan 2006 | disease of orbital part of eye adnexa | Barwon Health | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03303053 Comparator | May 2017 → Mar 2018 | Graves disease | Clinical Research Centre, Malaysia | Unknown | No outcome recorded |
| Phase 3 | NCT01436994 Comparator | Jul 2004 → Dec 2014 | thyroid gland disorder | Newcastle-upon-Tyne Hospitals NHS Trust | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carbimazole | “Tablet Carbimazole 30 mg daily, Tablet propanolol 40 mg twice daily for 4 weeks” NCT03303053 ↗ |
| Known as | Carbimazol | ChEMBL registry synonym — accepted as the source's own label CHEMBL508102 ↗ |
| Known as | Carbimazol henning | ChEMBL registry synonym — accepted as the source's own label CHEMBL508102 ↗ |
| Known as | Neo-mercazole 20 | ChEMBL registry synonym — accepted as the source's own label CHEMBL508102 ↗ |
| Known as | Neo-mercazole 5 | ChEMBL registry synonym — accepted as the source's own label CHEMBL508102 ↗ |
| Known as | NSC-758966 | ChEMBL registry synonym — accepted as the source's own label CHEMBL508102 ↗ |
| Action | Inhibit | “Anti thyroid drugs (ATDs) including methimazole, carbimazole, and propylthiouracil are effective treatments that inhibit thyroid hormone synthesis” NCT03303053 ↗1“Thyroid peroxidase inhibitor” CHEMBL508102 ↗ |
| Modality | Small molecule | — CHEMBL508102 ↗ |
| Target | TPO | “Thyroid peroxidase inhibitor” CHEMBL508102 ↗ |